Showing results (611-620 of 721) with videos related to
Sort By:
Pageof 73
Histopathology|May 7, 2015
The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomyLaurice K Fischer, Matthew H Katz, Sun M Lee, et al.Annals of Surgical Oncology|February 15, 2013
Frequency and intensity of postoperative surveillance after curative treatment of pancreatic cancer: a cost-effectiveness analysisChing-Wei D Tzeng, Daniel E Abbott, Scott B Cantor, et al.Journal of Cellular Biochemistry|January 18, 2014
Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX)Yukihiko Hiroshima, Ming Zhao, Ali Maawy, et al.Cancer|May 19, 2012
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicatorsMatthew H G Katz, Jason B Fleming, Priya Bhosale, et al.Cancer Gene Therapy|June 20, 2015
Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of pancreatic cancer enhances fluorescence-guided surgeryS Yano, Y Hiroshima, A Maawy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2021
Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic CancerAslamuzzaman Kazi, Liwei Chen, Shengyan Xiang, et al.Annals of Surgery|December 19, 2019
The Impact of Socioeconomic Deprivation on Clinical Outcomes for Pancreatic Adenocarcinoma at a High-volume Cancer Center: A Retrospective Cohort AnalysisBenjamin D Powers, William Fulp, Amina Dhahri, et al.Molecular Carcinogenesis|April 12, 2023
Translational relevance of SOS1 targeting for KRAS-mutant colorectal cancerDiego Alem, Xinrui Yang, Francisca Beato, et al.Annals of Surgical Oncology|September 10, 2015
The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative TherapyChristina L Roland, Matthew H G Katz, Ching-Wei D Tzeng, et al.Annals of Surgical Oncology|October 30, 2014
Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancerChristina L Roland, Anthony D Yang, Matthew H G Katz, et al.Pageof 73